Thrombosis and Haemostasis, Table of Contents Thromb Haemost 1966; 15(01/02): 143-160DOI: 10.1055/s-0038-1649418 Originalarbeiten — Original Articles — Travaux Originaux Schattauer GmbH Coagulopathies et Carcinomes Riches en Mucopolysaccharides Authors Author Affiliations F Bagnoud 1 Institut de Pathologie de l'Université de Genève Recommend Article Abstract Buy Article(opens in new window) Résumé Trois cas d’adénocarcinome mucipare sont rapportés. Ils ont en commun une importante dissémination hématogène de la tumeur et des thromboses. Chez deux d’entre eux, révolution se complique d’une diathèse hémorragique. L’autopsie révèle une précipitation massive de fibrine dans le système artériolocapillaire viscéral. Cette dyscrasie est classée dans le groupe des coagulopathies par consommation. Le rôle pathogénique des mucines tumorales dans la genèse des thromboses est discuté. Full Text References Bibliographie 1 Adelson E, Crosby W. H, Boeder W. H. Further studies of a hemostatic defect caused by intravenous dextran. J. Lab. clin. Med 45: 441-448 1955; 2 Alkjaersig N, Fletcher A. P, Sherry S. E-aminocaproic acid: an inhibitor of plasminogen activation. J. biol. Chem 234: 832-837 1959; 3 Amromin G. D, Wang S. K. Degenerative verrucal endocardiosis and myocardial infarction: report of two cases associated with mucus-producing bronchogenic carcinoma. Ann. int. Med 50: 1519-1529 1959; 4 Astrup T. Dans: Thrombolytic activity and related phenomena. 51 Schattauer; Stuttgart: 1961 5 Astrup T, Piper J. Interaction between fibrinogen and polysaccharide polysulfuric acids. Acta physiol, scand 11: 211-220 1946; 6 Barry W. E, Scarpelli D. Nonbacterial thrombotic endocarditis. Arch, intern. Med 109: 151-156 1962; 7 Bennike T, Müllertz S. Haemorrhagic diathesis associated with fibrinogenopenia and fibrinolysis. A report of two cases. Acta haemat. (Basel) 08: 147-154 1952; 8 Bergentz S. E, Eiken O, Nilsson I. M. The effect of dextran of various molecular wTeight on the coagulation in dogs. Thrombos. Diathes. haemorrh. (Stuttg.) 06: 15-24 1961; 9 Bettex-Galland M, Lüscher E. F, Simon G, Vassalli P. Induction of viscous metamorphosis in human blood platelets by means other than by thrombin. Nature (Lond.) 200: 1109-1110 1963; 10 Biggs R, Macfarlane R. G. Human blood coagulation and its disorders. 125 Oxford: Blackwell scientific publications; 1962 11 Bouvier G. A. Indications et contre-indications des inhibiteurs de protéases. Méd. et Hyg. (Genève) 621: 1109 1963; 12 Bouvier G. A, Bang N. U, Cliffton E. E. Une méthode d’évaluation différentielle de la thrombolyse in vivo. Schweiz, med. Wsehr 90: 1246-1249 1960; 13 Bouvier C. A, Gründlinger J. Etude des phénomènes de coagulation et de fibrinolyse par une méthode simple d’enregistrement optique continu. Schweiz, med. Wschr 41: 1451-1455 1963; 14 Case records of the Massachusetts General Hospital. New Engl. J. Med 256: 1004-1009 1957; 15 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta haemat. (Basel) 17: 237-246 1957; 16 Edwards E. A. Migrating thrombophlebitis associated with carcinoma. New. Engl. J. Med 240: 1031-1035 1949; 17 Fisher E. R, Baird W. F. The nature of arteriolar and capillary occlusion in patients with carcinoma. Amer. J. Path 32: 1185-1203 1956; 18 Fletcher F, Martin L. E, Ratcliffe L. Interaction of macromolecules and fibrinogen. Nature (Lond) 170: 319 1952; 19 Fountain J. R, Holman R. L. Acquired fibrinogen deficiency associated with carcinoma of the bronchus. Ann. intern. Med 52: 459-463 1960; 20 Frick P. G. Acute hémorragie syndrome with hypofibrinogenemia in metastatic cancer. Acta haemat. (Basel) 16: 11-29 1956; 21 Gitlin D, Craig J. M. Variations in the staining characteristics of human fibrin. Amer. J. Path 33: 267-283 1957; 22 Gitlin D, Craig J. M, Janeway C. A. Studies on the nature of fibrinoid in the collagen diseases. Amer. J. Path 33: 55-77 1957; 23 Green P, Bergman B. »Mucinemia«: Report of a case of carcinomatosis with a unique serum protein. Canad. med. Ass. J 86: 418-419 1962; 24 Humphrey J. H, Jaques R. The release of histamine and 5-hydroxytryptamine (serotonin) from platelets by antigen-antibody reactions (in vitro). J. Physiol 128: 9-27 1955; 25 Jennings W. K, Russell W. O. Phlebothrombosis associated with mucus-producing carcinomas of tail and body of pancreas. Clinico-pathologic study of two cases with necropsy. Arch. Surg 56: 186-198 1948; 26 Johnson A. International Commitee on Haemostasis and Thrombosis. St.Moritz. September 1965 27 Krecke H. J, Bohle A, Lasch H. G. Klinik und Histopathologie des menschlichen Sanarelli- Shwartzman-Phänomens. Méd. et Hyg. (Genève) 21: 1100-1103 1963; 28 Lafler C. J, Hinerman D. L. A morphologie study of pancreatic carcinoma with reference to multiple thrombi. Cancer (Philad) 14: 944-952 1961; 29 Lasch H. G, Krecke H. J, Bohle A. Physiopathologie du phénomène de Sanarelli-Shwartzman. Méd. et Hyg. (Genève) 21: 1099-1100 1963; 30 Lasch H. G, Krecke H. J, Rodriguez-Erdmann F, Sessner H. H, Schütterle G. Verbr auchskoagulopathien (Pathogenese und Therapie). Folia haemat. (Lpz.) Neue Folge 06: 325-330 1961; 31 Lüscher E. F. L’activation des enzymes protéolytiques du plasma sanguin. Méd. et Hyg. (Genève) 21: 1113-1114 1963; 32 Marchai G, Samama M, Leroux M. e. Agents actuels de la thérapeutique antifibrinolytique. Sem. Hôp. Paris 38: 1985-1992 1962; 33 McKay D. G, Mansell H, Hertig A. T. Carcinoma of body of pancreas with fibrin thrombosis andfibrinogenopenia. Cancer 06: 862-869 1953; 34 McKay D. G, Wahle G. H. Disseminated thrombosis in colon cancer. Cancer 08: 970-978 1955; 35 Nieiviarowski S, Kowalski E, Stachurska J. Influence of fibrinogen derived antithrombin (antithrombin VI) on the blood coagulation system. Acta biochim. pol 06: 43-53 1959; 36 Oclin L. Dans: Ciba Foundation Symposium on the Chemistry and Biology of Mucopolysaccharides. 234 J. & A. Churchill, Ltd; London: 1958 37 Oelbaum M. H, Strich S. J. Thrombophlebitis migrans and carcinoma of body and tail of pancreas. Brit. med. J 02: 907-909 1953; 38 Pearse A. G. E. Histochemistry theoretical and applied. 170 J. &. A. Churchill, Ltd: London; 1960 39 Perlow S, Daniels J. L. Venous thrombosis and obscure visceral carcinoma. Report of ten cases. Arch, intern. Med 97: 184-188 1956; 40 Ponder E. Revêtement des plaquettes humaines et des globules rouges par les dextranes. Rev. Hémat 12: 11-15 1957; 41 Ratnoff O. D. The effect of clotting on the spontaneous activation of plasmin. (abstract). J. clin. Invest 34: 958 1955; 42 Boss S. W, Ebert R. V. Microelectrophoresis of blood platelets and the effects of dextran. J. clin. Invest 38: 155-160 1959; 43 Sasaki S, Noguchi H. Interaction of fibrinogen with dextran sulfate. J. gen. Physiol 43: 1-12 1959; 44 Scott J. S. Blood coagulation failure in obstetrics. Brit. med. J II: 290-293 1955; 45 Sherry S, Fletcher A. P, Alkjaersig N, Sawyer W. D. Epsilon-amino-caproic acid, cc a potent anti-fibrinolytic agent.” Trans. Ass. Amer. Phycns 72: 62-70 1959; 46 Sigstad H, Lamvik J. Haemorragic diathesis, fibrinolysis and fibrinogenopenia in prostatic cancer. Report of a case. Acta med. scand 173: 215-222 1963; 47 Simon G, Ghatelanat F. Fibrine et fibrinoïde dans les glomérulopathies. Etude comparée en pathologie expérimentale et spontanée. Path, et Microbiol. (Basel) 26: 191-205 1963; 48 Siqueira M, Nelson Jr. R. A. Platelet agglutination by immune complexes and its possible role in hypersensitivity. J. Immunol 86: 516-525 1961; 49 Sproul E. E. Carcinoma and venous thrombosis; frequency of association of carcinoma in body or tail of pancreas with multiple venous thrombosis. Amer. J. Cancer 34: 566-585 1938; 50 Tagnon H. J, Shidman P, Whitmore W. F, Kravitz S. C. The hemorrhagic syndrome of metastatic prostatic cancer and its treatment, (abstract). J. clin Invest 31: 666 1952; 51 Vassalli P, Morris R. H, McCluskey R. T. The pathogenic role of fibrin deposition in the glomerular lesions of toxemia of pregnancy. J. exp. Med 118: 467-477 1963; a 52 Vassalli P, Simon G, Rouiller C. Electron microscopic study of glomerular lesions resulting from intravascular fibrin formation. Amer. J. Path 43: 579-617 1963; b 53 Walton K. W. Investigation of the toxicity of a series of dextran sulphates of varying molecular weight. Brit. J. Pharmacol 09: 1-14 1954; 54 Winckelmann G, Schirmeister J, Helms M. Fibrinolyse als Blutungsursache beim metastasierenden Magencarcinom. Klin. Wschr 40: 748-752 1962;
